| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8229566 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 6 Pages |
Abstract
The results suggest that hyperfractionated PBT is safe and effective for patients with esophageal cancer. Further studies are needed to establish the appropriate role and treatment schedule for use of PBT for esophageal cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Masashi M.D., Shinji M.D., Toshiyuki M.D., Takayuki M.D., Yoshiko M.D., Nobuyoshi M.D., Akira M.D., Hideo M.D., Koji M.D., Hideyuki M.D.,